TITLE

The patient-based outcome of upper-extremity surgeries using the DASH questionnaire and the effect of disease activity of the patients with rheumatoid arthritis

AUTHOR(S)
Ishikawa, Hajime; Murasawa, Akira; Nakazono, Kiyoshi; Abe, Asami; Otani, Hiroshi; Netsu, Tahahiro; Sakai, Takehito; Sato, Hiroe
PUB. DATE
August 2008
SOURCE
Clinical Rheumatology;Aug2008, Vol. 27 Issue 8, p967
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The Disabilities of the Arm, Shoulder and Hand (DASH) is a standardized patient-based outcome measure, which assesses integrated upper-extremity disorders. The objectives of this study were to investigate subjective outcome after upper-extremity surgeries for the patients with rheumatoid arthritis (RA) using the DASH questionnaire (Japanese version) and to investigate the influence of disease activity on the surgical outcome using the Disease Activity Score (DAS) 28-CRP(4). Approximately 127 surgical procedures for the upper extremities in 127 patients with RA were recruited in this study. Surgeries were performed in 4 shoulders, 35 elbows, 60 wrists and 28 hands. The DASH score (disability/symptom score) was investigated just before surgery and at follow-up. The mean follow-up period after the surgery was 15 months on average (range, 6 to 24 months). The preoperative DASH score (disability/symptom score) 50 ± 23 (mean ± SD) decreased significantly to 38 ± 23 at the follow-up ( n = 127, p < 0.01). Standardized response mean and effect size revealed a medium effect of −0.6 and −0.5. Patients with various degrees of disease activity improved and the improvements per se were comparable of preoperative disease activity and postoperative response to medical treatment. A favorable subjective outcome of rheumatoid upper-extremity surgeries can be anticipated under the good control of disease activity.
ACCESSION #
32960729

 

Related Articles

  • How does the Short Form 36 Health Questionnaire (SF-36) in Rheumatoid Arthritis (RA) Relate to RA Outcome Measures and SF-36 Population Values? A Cross-Sectional Study. Birrell, F. N.; Hassell, A. B.; Jones, P. W.; Dawes, P. T. // Clinical Rheumatology;May2000, Vol. 19 Issue 3, p195 

    : The aim of the study was to show that the SF-36 is a practical tool for use on outpatients with RA, to examine the relationship between the SF-36 and indices of outcome in RA, and to compare the results with population norms and other disease states. Eighty-six consecutive RA patients...

  • The effect of low-dose prednisone on bone mineral density in Peruvian rheumatoid arthritis patients. Chung, Cecilia P.; Russell, Anthony S.; Segami, Maria I.; Ugarte, César A. // Rheumatology International;Mar2005, Vol. 25 Issue 2, p114 

    Objective: The aim of this study was to determine the difference between bone mineral density (BMD) of rheumatoid arthritis (RA) patients on low-dose prednisone and matched RA patients without prior systemic corticosteroid therapy. Methods: Ninety patients attending our clinics and receiving 10...

  • Adalimumab for Rheumatoid Arthritis? Ebell, Mark; Kripke, Clarissa // American Family Physician;2/1/2006, Vol. 73 Issue 3, p435 

    Answers a question on the safety and effectiveness of adalimumab (Humira) for rheumatoid arthritis. Required dosage of adalimumab; Effectiveness of the combination of adalimumab with methotrexate; Indications for adalimumab.

  • White cells count in smokers affected by rheumatic diseases. Bartolone, Sebastiano; Calzavara, Emilse; Russo, Giuseppina; Carnì, Antonio; Mannucci, Carmen; Pieratti, Antonella; Caputi, Achille; Calapai, Gioacchino // Rheumatology International;Jan2012, Vol. 32 Issue 1, p109 

    Evidence shows that tobacco smoking interacts with development of rheumatic diseases. Increase in white cells count (leukocytosis) is frequently present, and in smokers, it is considered a biomarker of cardiovascular risk. Aim of the study is to evaluate this biomarker in smokers with rheumatic...

  • Need to Avoid Handshakes. Kellery, Kay // Arthritis Today;Mar/Apr2008, Vol. 22 Issue 2, p12 

    The article seeks advice for dealing with the hand-shaking experienced by her daughter who was diagnosed with rheumatoid arthritis. The shaking of the hands can be extremely painful and the patient does not want to appear rude or call attention to her condition.

  • New developments in ochronosis: review of the literature. Keller, Julie M.; Macaulay, William; Nercessian, Ohannes A.; Jaffe, Israeli A. // Rheumatology International;Mar2005, Vol. 25 Issue 2, p81 

    Ochronosis commonly affects all connective tissue. Recognition of changes secondary to the deposition of ochronotic pigments has increased with advances in diagnostic technology, allowing both improved imaging and early biochemical and genetics-based diagnosis of alkaptonuria, the cause of...

  • Adalimumab provides "clinically important" HRQOL gains in RA.  // PharmacoEconomics & Outcomes News;12/3/2005, Issue 492, p13 

    The article presents information on a study conducted on the benefits of adalimumab to patients with severe, reactive rheumatoid arthritis. The results of the study were presented at the 8th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research which...

  • Monoarticular septic arthritis in a patient with juvenile rheumatoid arthritis under etanercept treatment. Lin, Kai-Cheng; Liang, Chi-Di; Yang, Kuender; Yu, Hong-Ren; Kuo, Ho-Chang // Rheumatology International;May2012, Vol. 32 Issue 5, p1383 

    A 7-year-old girl with polyarticular type juvenile rheumatoid arthritis (JRA) presented with acute onset of right hip pain with limited range of motion and fever within the past two days. She had received etanercept for more than one year. Percutaneous arthrocentesis was performed and showed a...

  • Editorials: Sulphasalazine in rheumatoid arthritis: an old drug revived. Neumann, V. C.; Grindulis, K. A. // Journal of the Royal Society of Medicine;Mar1984, Vol. 77 Issue 3, p169 

    The article discusses the benefits of sulphasalazine in treating rheumatoid arthritis. Sulphasalazine is an old drug which is a compound of sulphapyridine and 5-aminosalicylic acid linked by an azo bond. The benefits of salicylates in rheumatoid arthritis have an excellent effect on the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics